RGNX

Regenxbio Stock Analysis

AI Rating

Fair
  • Quality1/10
  • Growth↑ 6/10
  • Momentum↓ 3/10
Regenxbio sales and earnings growth
RGNX Growth
Good
  • Revenue Y/Y↑ 91.30%
  • EPS Y/Y↑ 31.08%
  • FCF Y/Y↑ 42.47%
Regenxbio gross and profit margin trends
RGNX Profitability
Neutral
  • Gross margin ↑ 87.20%
  • EPS margin↓ -110.30%
  • ROIC↓ -26.00%
Regenxbio net debt vs free cash flow
RGNX Risk
Good
  • Debt / Equity↓ 1.7
  • Debt / FCF↓ 2.0
  • Interest coverage↓ -3.2

Regenxbio stock volatility is higher than the overall market. We give it a Good risk rating.

More Biotechnology stocks ↗